Fluorescent labelling of membrane fatty acid transporter CD36 (SR-B2) in the extracellular loop

被引:5
|
作者
Liu, Yilin [1 ]
Rodriguez-Calvo, Ricardo [1 ,3 ]
Wang, Shujin [1 ]
Zhu, Xiaoqing [1 ]
Broers, Jos L. V. [2 ]
Glatz, Jan F. C. [1 ]
Luiken, Joost J. F. P. [1 ]
Neumann, Dietbert [1 ,4 ]
机构
[1] Maastricht Univ, Dept Mol Genet, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
[2] Maastricht Univ, Dept Mol Cell Biol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
[3] Univ Rovira & Virgili, Spanish Biomed Res Ctr Diabet & Associated Metab, Inst Invest Sanitaria Pere Virgili IISPV, Res Unit Lipids & Atherosclerosis,St Joan Univ Ho, Reus, Spain
[4] Maastricht Univ, Dept Pathol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
来源
PLOS ONE | 2019年 / 14卷 / 01期
关键词
RAT CARDIAC MYOCYTES; CONTRACTILE DYSFUNCTION; SARCOLEMMAL FAT/CD36; INSULIN; PROTEIN; TRANSLOCATION; METABOLISM; DIET;
D O I
10.1371/journal.pone.0210704
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Context Upon palmitate oversupply, membrane fatty acid-transporter CD36 (SR-B2) permanently translocates from endosomal storage to the sarcolemma, inducing lipotoxicity. CD36 trans location results from endosomal alkalinisation elicited by palmitate-induced disattachment of the cytoplasmic V-1-subcomplex from the membrane-integrated V-0-subcomplex of vacuolar-type H+-ATPase. Objective Develop a CD36 fluorescent labeling technique as initial step towards live cell imaging. Methods Three human CD36 (hCD36) mutants were constructed via insertion of a tetracysteine motif at different positions within the extracellular domain. Constructs were lentivirally transduced for subsequent CD36 labeling with fluorescein-arsenical hairpin-binder (FlAsH). Cell imaging was combined with V-0/V-1 immunostaining and Western blotting. Results Transduction of hCD36-wildtype and mutants yielded corresponding proteins in HL-1 cardiomyocytes. Tetracysteine mutant-2 (hCD36-TC2) showed similar fatty acid uptake to wild type. FlAsH staining revealed a speckled pattern reminiscent of endosomes. We found decreased V-1 co-localization with CD36 upon high-palmitate culturing. Conversely, V-0 consistently co-localized with CD36. Conclusion hCD36-TC2 is a possible candidate for application of biarsenical dyes in live imaging studies pending further investigation. Our data is compatible with V-0/V-1 disassembly in high-palmitate-treated cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] CD36/fatty acid translocase in rats: Distribution, isolation from hepatocytes, and comparison with the scavenger receptor SR-B1
    Zhang, XQ
    Fitzsimmons, RL
    Cleland, LG
    Ey, PL
    Zannettino, ACW
    Farmer, EA
    Sincock, P
    Mayrhofer, G
    LABORATORY INVESTIGATION, 2003, 83 (03) : 317 - 332
  • [32] Estradiol enhances effects of fructose rich diet on cardiac fatty acid transporter CD36 and triglycerides accumulation
    Koricanac, Goran
    Tepavcevic, Snezana
    Romic, Snjezana
    Zivkovic, Maja
    Stojiljkovic, Mojca
    Milosavljevic, Tijana
    Stankovic, Aleksandra
    Petkovic, Marijana
    Kamceva, Tina
    Zakula, Zorica
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 694 (1-3) : 127 - 134
  • [33] Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo
    Corpeleijn, E.
    Pelsers, M. M. A. L.
    Soenen, S.
    Mensink, M.
    Bouwman, F. G.
    Kooi, M. E.
    Saris, W. H. M.
    Glatz, J. F. C.
    Blaak, E. E.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2008, 59 (01): : 77 - 83
  • [34] 脂肪酸移位酶CD36/SR-B2及其介导的长链脂肪酸跨膜转运
    骆东梅
    汪水平
    赵雪莉
    韩雪峰
    动物营养学报, 2019, 31 (06) : 2552 - 2559
  • [35] The fatty acid transporter FAT/CD36 and the glucose transporter GLUT4 are mobilized to the sarcolemma via different signaling pathways
    Luiken, JJFP
    Koonen, DPY
    Coort, SLM
    Bonen, A
    Glatz, JFC
    CHEMISTRY AND PHYSICS OF LIPIDS, 2004, 130 (01) : 29 - 30
  • [36] Fatty acid translocase FAT/CD36 translocation to plasma membrane in fa/fa rat hepatocytes
    Buque, X.
    Cano, A.
    Ochoa, B.
    Aspichueta, I.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2008, 154 : S44 - S44
  • [37] Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance
    Corpeleijn, E.
    van der Kallen, C. J. H.
    Kruijshoop, M.
    Magagnin, M. G. P.
    de Bruin, T. W. A.
    Feskens, E. J. M.
    Saris, W. H. M.
    Blaak, E. E.
    DIABETIC MEDICINE, 2006, 23 (08) : 907 - 911
  • [38] The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus
    Castelblanco, Esmeralda
    Sanjurjo, Lucia
    Barranco-Altirriba, Maria
    Falguera, Mireia
    Hernandez, Marta
    Soldevila, Berta
    Sarrias, Maria-Rosa
    Franch-Nadal, Josep
    Arroyo, Juan Antonio
    Fernandez-Real, Jose-Manuel
    Alonso, Nuria
    Mauricio, Didac
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [39] A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice
    Gauvin, Jade
    Fregeau, Genevieve
    Elimam, Hanan
    Menard, Liliane
    Huynh, David
    Le, Catherine
    Ahsanullah, Ahsanullah
    Lubell, William D.
    Ong, Huy
    Marleau, Sylvie
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Enhanced myocardial glucose uptake in individuals with a deficiency in long-chain fatty acid transporter (CD36 deficiency)
    Fukuchi, K
    Nozaki, S
    Yosizumi, T
    Hasegawa, S
    Uehara, T
    Nakagawa, T
    Tomiyama, Y
    Yamashita, S
    Matsuzawa, Y
    Nishimura, T
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 152P - 152P